 |
|
Study finds association between hepatitis B and pancreatic cancer
September 30, 2008Study Summary: Hepatitis B could be a risk factor for pancreatic cancer
A new study has shown that evidence of past hepatitis B infection was twice as common in people with pancreatic cancer than in healthy controls. This study is the first to report an association between past exposure to the hepatitis B virus and pancreatic cancer, but researchers cautioned that more studies are necessary to evaluate the nature of the link.
"While our findings indicate that past exposure to hepatitis B is associated with the development of pancreatic cancer, more research is needed to determine whether this relationship is one of cause and effect," said lead author Manal M. Hassan, MD, PhD, assistant professor at The University of Texas M. D. Anderson Cancer Center. "If these findings can be confirmed by other studies, hepatitis B could be another risk factor for pancreatic cancer that is readily modifiable with treatment, and even preventable with a vaccine."
In this study, Dr. Hassan and her colleagues compared evidence of hepatitis B and C infection (as determined by blood tests assessing antibodies to these viruses) between 476 patients with pancreatic cancer and 879 matched healthy individuals. Evidence of past exposure to hepatitis B was found in 7.6 percent of patients with pancreatic cancer versus 3.2 percent of controls. The association between hepatitis B exposure and pancreatic cancer remained statistically significant even after controlling for other risk factors, such as smoking. People with both diabetes (an established risk factor for pancreatic cancer) and hepatitis B exposure had a 7-fold increase in pancreatic cancer risk, compared to controls. No association was observed between hepatitis C exposure and pancreatic cancer.
The authors noted that past studies have reported the presence of hepatitis B antigens in pancreatic fluids; others have identified impaired pancreatic function in people with chronic hepatitis B infection. These findings suggest that the hepatitis B virus may cause inflammation or DNA damage in the pancreas, which could increase cancer risk.
The researchers also indicated that there may be an increased risk of liver failure after chemotherapy treatment among patients with pancreatic cancer who have a history of hepatitis B infection. Dr. Hassan noted that if their findings are confirmed, oncologists may want to consider checking the hepatitis B status of their patients with pancreatic cancer before beginning chemotherapy.
About Pancreatic Cancer and Hepatitis B
Pancreatic cancer is estimated to strike 37,680 people in the U.S. in 2008, taking 34,290 lives. Because it is usually advanced by the time patients experience symptoms, it is very difficult to cure. Smoking and diabetes raise the risk of pancreatic cancer, but the disease also develops in people without these risk factors.
Two million people in the U.S. are currently living with chronic hepatitis B infection. While most new cases in previously healthy adults are cleared by the immune system within a few months, many people -- especially those infected as newborns and children -- develop chronic, lifelong infections.
ASCO Perspective
Patrick J. Loehrer, Sr., MD, Deputy Director and Medical Director, Indiana University Cancer Center
"Pancreatic cancer is an aggressive disease that is very difficult to treat successfully. In large part, it is a result of the inability to prevent and diagnose early as treatment for advanced disease is palliative at best. If these data are confirmed by larger studies, they would highlight a new risk factor for this lethal cancer, a virus for which both treatment and a vaccine already exist. Whether this could then lead to an impact in the incidence of this disease requires further study."
American Society of Clinical Oncology
In this study, Dr. Hassan and her colleagues compared evidence of hepatitis B and C infection (as determined by blood tests assessing antibodies to these viruses) between 476 patients with pancreatic cancer and 879 matched healthy individuals. Evidence of past exposure to hepatitis B was found in 7.6 percent of patients with pancreatic cancer versus 3.2 percent of controls. The association between hepatitis B exposure and pancreatic cancer remained statistically significant even after controlling for other risk factors, such as smoking. People with both diabetes (an established risk factor for pancreatic cancer) and hepatitis B exposure had a 7-fold increase in pancreatic cancer risk, compared to controls. No association was observed between hepatitis C exposure and pancreatic cancer.
The authors noted that past studies have reported the presence of hepatitis B antigens in pancreatic fluids; others have identified impaired pancreatic function in people with chronic hepatitis B infection. These findings suggest that the hepatitis B virus may cause inflammation or DNA damage in the pancreas, which could increase cancer risk.
The researchers also indicated that there may be an increased risk of liver failure after chemotherapy treatment among patients with pancreatic cancer who have a history of hepatitis B infection. Dr. Hassan noted that if their findings are confirmed, oncologists may want to consider checking the hepatitis B status of their patients with pancreatic cancer before beginning chemotherapy.
About Pancreatic Cancer and Hepatitis B
Pancreatic cancer is estimated to strike 37,680 people in the U.S. in 2008, taking 34,290 lives. Because it is usually advanced by the time patients experience symptoms, it is very difficult to cure. Smoking and diabetes raise the risk of pancreatic cancer, but the disease also develops in people without these risk factors.
Two million people in the U.S. are currently living with chronic hepatitis B infection. While most new cases in previously healthy adults are cleared by the immune system within a few months, many people -- especially those infected as newborns and children -- develop chronic, lifelong infections.
ASCO Perspective
Patrick J. Loehrer, Sr., MD, Deputy Director and Medical Director, Indiana University Cancer Center
"Pancreatic cancer is an aggressive disease that is very difficult to treat successfully. In large part, it is a result of the inability to prevent and diagnose early as treatment for advanced disease is palliative at best. If these data are confirmed by larger studies, they would highlight a new risk factor for this lethal cancer, a virus for which both treatment and a vaccine already exist. Whether this could then lead to an impact in the incidence of this disease requires further study."
American Society of Clinical Oncology
Pancreatic Cancer Current Events and Pancreatic Cancer News RSSResearch highlights new approaches to prevent blood clots
Blood clotting, or coagulation, is an important process that prevents excessive bleeding when a blood vessel is injured.
Stanford blood scanner detects even faint indicators of cancer
A team led by Stanford researchers has developed a prototype blood scanner that can find cancer markers in the bloodstream in early stages of the disease, potentially allowing for earlier treatment and dramatically improved chances of survival.
2 new compounds show promise for eliminating breast cancer tumors
Two new compounds created by a University of Central Florida professor show early promise for destroying breast cancer tumors.
The miseries of allergies just may help prevent some cancers, study finds
There may be a silver -- and healthy -- lining to the miserable cloud of allergy symptoms: Sneezing, coughing, tearing and itching just may help prevent cancer -- particularly colon, skin, bladder, mouth, throat, uterus and cervix, lung and gastrointestinal tract cancer, according to a new Cornell study.
Cancer drugs my build and not tear down blood vessels
Scientists have thought that one way to foil a tumor from generating blood vessels to feed its growth - a process called angiogenesis - was by creating drugs aimed at stopping a key vessel growth-promoting protein. But now the opposite seems to be true.
UC Davis researchers discover Achilles' heel in pancreatic cancer
UC Davis Cancer Center researchers have discovered a metabolic deficiency in pancreatic cancer cells that can be used to slow the progress of the deadliest of all cancers.
Jefferson Department of Surgery announces new pancreas tumor registry
Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, announces the establishment of the new Jefferson Pancreas Tumor Registry (JPTR).
Supercomputer provides massive computational boost to biomedical research at TGen
In less time than the blink of an eye, the Translational Genomics Research Institute's new supercomputer at Arizona State University can do operations equal to every dollar in the recent Wall Street bailout.
Hepatitis B exposure may increase risk for pancreatic cancer
In a first-of-its-kind finding, researchers at The University of Texas M. D. Anderson Cancer Center have discovered that exposure to the hepatitis B virus (HBV) may increase the risk of pancreatic cancer.
Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
A research team, led by investigators at the Department of Surgery at Jefferson Medical College of Thomas Jefferson University and the Kimmel Cancer Center at Jefferson, has achieved a substantial "kill" of pancreatic cancer cells by using nanoparticles to successfully deliver a deadly diphtheria toxin gene.
More Pancreatic Cancer Current Events and Pancreatic Cancer News Articles
 | 100 Q&A About Pancreatic Cancer (100 Questions Series) by Joanne Frankel Kelvin Eileen O'Reilly EMPOWER YOURSELF! Whether you’re a newly diagnosed pancreatic cancer patient, a survivor, or a friend or relative of someone with pancreatic cancer, this book offers help. The only text to provide a doctor’s and patient’s view, 100 Questions & Answers About Pancreatic Cancer gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of... |
 | Pancreatic Cancer (M.D. Anderson Solid Tumor Oncology Series) Since the previous M.D. Anderson Solid Tumor Oncology Series publication on pancreatic cancer, there have been major advances in our understanding of molecular events which underlie pancreatic cancer development, both in the sporadic and inherited forms. We have seen the development of the first mouse models that accurately recapitulate features of the human disease. Several landmark clinical... |
 | The Official Patient's Sourcebook on Pancreatic Cancer: A Revised and Updated Directory for the Internet Age by Icon Health Publications This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to pancreatic cancer (also Cancer pancreas; Pancreatic cancer), from the... |
 | My Journey With Pancreatic Cancer by Calvin E. Rains Sr. This book is shared to help all understand the cancer affecting the pancreas which is a vital organ in the digestion of food. Pancreatic cancer is one of the most deadly of cancers affecting the human body. Less than 5% of those diagnosed with Pancreatic Cancer survive the first year. This book is intended to help the patient, their families, and friends to understand the dangers and possible... |
 | Pancreatic Cancer by Daniel D. Von Hoff (Editor) Praise for the book “An outstanding text covering all aspects of pancreatic cancer, from embryology through genetics and pathology, and including all avenues of treatment. There are 112 internationally recognized authors, the book is marvelously illustrated, and is a must for all scientists and clinicians interested in neoplasms of the pancreas. It is currently the most up-to-date and... |
| Pancreatic Cancer (American Cancer Society Atlas of Clinical Oncology) by John L. Cameron At present, there are approximately 28,300 new cases of pancreatic cancer in the United States. It is the fourth leading cause of cancer death in men and women. Approximately 2 out of 10 patients with cancer of the pancreas will live at least one year after the cancer is found, but only a very few will survive for five or more years. The editors have brought together a stellar team of... | |
 | Pancreatic Cancer (Recent Results in Cancer Research) Although pancreatic cancer is one of the most serious forms of cancers, the outlook for patients could be improved. The lack of clinical symptoms of early, surgically removable disease most often limits curative treatment options. The aggressive tumor cell biology, leading to a locally advanced nature of the disease and to early metastases, allows curative resection in only 20% of patients at the... |
| 100 Questions & Answers About Pancreatic Cancer, 2nd Edition (100 Questions & Answers about . . .) by Eileen O'Reilly Empower yourself!Whether you're a newly diagnosed pancreatic cancer patient, a survivor, or friend or relative of someone with pancreatic cancer, this book offers help. The only text to provide a doctor's and a patient's view, 100 Questions & Answers About Pancreatic Cancer, Second Edition gives you authoritative, practical answers to your questions about treatment options, post-treatment quality... | |
 | Pancreatic Cancer Medical Guide by Qontro Medical Guides The Pancreatic Cancer Medical Guide is a publication which has been designed to better help readers understand Pancreatic Cancer. This Qontro Medical Guide has been designed with the reader in mind, and is a useful information source for readers at all levels looking to learn more about Pancreatic Cancer. The Pancreatic Cancer Medical Guide is highly recommended for those interested in... |
| Pancreatic Cancer: Current and Emerging Trends in Detection and Treatment (Cancer and Modern Science) by Amy Sterling Casil |
| © 2009 BrightSurf.com |